tirzepatide crohn's disease & Disease: Safe Weight Loss GLP-1s and Crohn's Disease: Safety,

Dong, C

All patients were in a stable phase of illness, defined as a change of no more than 10 points in their Social and Occupational Functioning Assessment Scale (SOFAS) score (defined in DSM-IV [44]) between assessment 6 weeks prior to and immediately prior to study participation

O.CorkeyB

PMC (PMC12469573)

CKD is a relentless wildfire that sets out to engulf the land beneath a patient's (and a nephrologist's) feet in totality, sooner or later

Patients with active suicidal ideation, recent psychiatric hospitalization, or unstable bipolar disorder should not start a GLP-1 agent through any telehealth platform without documented coordination with their treating psychiatrist